Trk 17: Rare/Orphan Diseases [
clear filter]
4:00pm EDT
#276: Using Input from Patient Communities to Develop PRO Instruments
Chair
Medical Affairs Lead, ASPIRE Unit, Actelion
15 years’ experience across medical affairs, product development strategy and new product planning, regulatory affairs, business development, strategy: Former Board President, International Pemphigus and Pemphigoid Foundation (rare disease foundation); Senior Medical Director, Archimedes...
Read More →
Speakers
Principal Consultant, Gwaltney Consulting
Dr. Gwaltney’s work focuses on the development of innovative methods to measure patient-centered outcomes in clinical trials. He has published numerous articles and book chapters addressing how the patient’s perspective can be examined to better understand product efficacy and...
Read More →EP
Associate Director, Clinical Outcome Assessments Staff, OND, CDER, FDA
Dr. Papadopoulos serves as the Associate Director of the Clinical Outcome Assessments Staff in the Office of New Drugs in the Center for Drug Evaluation and Research (CDER). The staff provides consultation to CDER’s Review Divisions as well as other FDA Centers on clinical outcome...
Read More →
Tuesday June 28, 2016 4:00pm - 5:15pm EDT
103C
Pennsylvania Convention Center 1101 Arch Street, Philadelphia, PA 19107 USA
Trk 17: Rare/Orphan Diseases,
Session
- Credit Type ACPE, CME, IACET, RN
- Audience Intermediate
- Featured Topics Patient Engagement
- Interest Area Study Endpoints, Clinical Research, Patient Engagement
- format json
- Interest Area Study Endpoints,Clinical Research,Patient Engagement
- Featured Topics Patient Engagement
- Credit Type ACPE, CME, IACET, RN
- Tags Session